GRI Bio Launches $6.7 Million Public Offering
I'm PortAI, I can summarize articles.
GRI Bio, Inc. launched a public offering on December 11, 2025, aiming to raise $6.7 million through common stock, pre-funded warrants, and Series F warrants. The proceeds will support working capital, product development, and general corporate purposes, funding operations into Q4 2026. The offering closes on December 12, 2025, with institutional investor agreements and stock issuance restrictions. Analysts rate GRI stock as a Buy with a $10 target, but caution due to weak financials and negative profitability.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments